Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Sports Medicine CoHKSE:01609 -0.21%20 PS Ratio is 55.14 as of Aug. 22, 2026, which is 15% below its 10-year median of 65.09. GuruFocus rates HKSE:01609 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 803 Medical Devices & Instruments companies, Star Sports Medicine Co ranks worse than 95.77% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Star Sports Medicine Co's share price is HK$143.80.
Star Sports Medicine Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2.61. Hence, Star Sports Medicine Co's PS Ratio for today is 55.14.
The historical rank and industry rank for Star Sports Medicine Co's PS Ratio or its related term are showing as below:
HKSE:01609'
s PS Ratio Range Over the Past 10 Years
Min: 45.97 Med: 65.09 Max: 77.84
Current: 55.14
During the past 4 years, Star Sports Medicine Co's highest PS Ratio was 77.84. The lowest was 45.97. And the median was 65.09.
HKSE:01609's PS Ratio is ranked worse than 95.77% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.96
vs HKSE:01609: 55.14
During the past 4 years, Star Sports Medicine Co's highest 3-Year average Revenue per Share Growth Rate was 39.60% per year. The lowest was 39.60% per year. And the median was 39.60% per year.
Star Sports Medicine Co (HKSE:01609) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Star Sports Medicine Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Sports Medicine Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Star Sports Medicine Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Star Sports Medicine Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Star Sports Medicine Co's Share Price of today is HK$143.80. Star Sports Medicine Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$2.61.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Star Sports Medicine Co (HKSE:01609) has a PS Ratio of 55.14 as of Aug. 22, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Star Sports Medicine Co and its competitors. This is 15% below median its historical median of 65.09. Over the past decade, Star Sports Medicine Co's PS Ratio has ranged from 45.97 to 77.84. According to the industry distribution chart, Star Sports Medicine Co ranks #769 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 95.8%.
Is Star Sports Medicine Co's PS Ratio too high?
Star Sports Medicine Co's current PS Ratio of 55.14 is 15% below median its 10-year median of 65.09. Over the past 10 years, this metric has ranged from a low of 45.97 to a high of 77.84. The Medical Devices & Instruments industry median PS Ratio is 2.96. Star Sports Medicine Co's value of 55.14 is 1762.8% above this industry median. Based on the distribution chart, Star Sports Medicine Co ranks #769 out of 803 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Star Sports Medicine Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Star Sports Medicine Co's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Star Sports Medicine Co ranks #769 out of 803 companies for PS Ratio. This places Star Sports Medicine Co in the lower half of its industry. The industry median PS Ratio is 2.96. Star Sports Medicine Co's value of 55.14 is 1762.8% above this benchmark. Historically, Star Sports Medicine Co's own PS Ratio has ranged from 45.97 to 77.84 over the past decade. While the company's 10-year median is 65.09 vs. the industry median of 2.96, Star Sports Medicine Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.96, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Sports Medicine Co's current PS Ratio of 55.14 is 1762.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Star Sports Medicine Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Sports Medicine Co's current PS Ratio is 55.14, which is 15% below median its own 10-year median of 65.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Sports Medicine Co stock overvalued right now?
Star Sports Medicine Co (HKSE:01609) has a current PS Ratio of 55.14. The current PS Ratio is 55.14, which is 15% below median its 10-year median of 65.09 and 1762.8% above the Medical Devices & Instruments industry median of 2.96. Star Sports Medicine Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Star Sports Medicine Co (HKSE:01609), the current PS Ratio is 55.14 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Star Sports Medicine Co Ltd is a China-based medical device company specializing in clinical sports medicine solutions. It is principally engaged in the research and development and sales of medical devices and equipment in the field of sports medicine. The product line covers medical implants, surgical equipment and associated medical consumables. The company has only one reportable operating segment, which is the sale of sports medicine products. It derives revenue from the sales of (i) medical implants and (ii) surgical equipment and associated medical consumables, with the majority of revenue generated from the sales of Medical implants. Geographically, the maximum revenue is derived from the Chinese mainland.
20GF Score
Get the complete analysis for HKSE:01609
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01609 has been successfully added to your 
